Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier and get daily trading ideas and historical data downloads. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | More
 
or
Watchlist | Portfolio
Site News
Contact
Market:

Agex Therapeutics Inc (AGE)

Agex Therapeutics Inc (AGE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates SMMF, RPT, AGE PR Newswire - Wed Oct 18, 2023

/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...

SMMF : 27.20 (+8.45%)
RPT : 12.83 (-2.51%)
AGE : 11.10 (-11.90%)
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates AGE, NXGN, AVTA, SPLK PR Newswire - Mon Oct 9, 2023

/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...

AGE : 11.10 (-11.90%)
NXGN : 23.94 (+0.13%)
AVTA : 25.99 (-0.04%)
SPLK : 156.90 (+0.25%)
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates AVID, SMMF, RPT, AGE PR Newswire - Wed Oct 4, 2023

/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...

AVID : 27.04 (unch)
SMMF : 27.20 (+8.45%)
RPT : 12.83 (-2.51%)
AGE : 11.10 (-11.90%)
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates NXGN, RPT, THRN, AGE PR Newswire - Tue Sep 26, 2023

/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...

NXGN : 23.94 (+0.13%)
RPT : 12.83 (-2.51%)
THRN : 10.19 (-0.10%)
AGE : 11.10 (-11.90%)
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates ABCM, AGE, ACER, NXGN PR Newswire - Mon Sep 18, 2023

/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...

ABCM : 23.99 (+0.04%)
AGE : 11.10 (-11.90%)
ACER : 0.6601 (-17.95%)
NXGN : 23.94 (+0.13%)
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates WRK, AGE, ACER PR Newswire - Tue Sep 12, 2023

/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...

WRK : 47.99 (+0.88%)
AGE : 11.10 (-11.90%)
ACER : 0.6601 (-17.95%)
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates THRN, ABCM, AGE, ACER PR Newswire - Tue Sep 5, 2023

/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...

THRN : 10.19 (-0.10%)
ABCM : 23.99 (+0.04%)
AGE : 11.10 (-11.90%)
ACER : 0.6601 (-17.95%)
Shareholder Alert: Ademi LLP investigates whether AgeX Therapeutics, Inc. has obtained a Fair Price in its transaction with Serina PR Newswire - Wed Aug 30, 2023

/PRNewswire/ -- Ademi LLP is investigating AgeX (NYSE American: AGE) for possible breaches of fiduciary duty and other violations of law in its transaction...

AGE : 11.10 (-11.90%)
AgeX Therapeutics Receives Stock Exchange Deficiency Letter Business Wire - Wed Apr 26, 2023

AgeX Therapeutics , Inc. (“AgeX”; NYSE American: AGE), a biotechnology company developing therapeutics for human aging and regeneration, announced today that on April 20, 2023 it received a letter...

AGE : 11.10 (-11.90%)
AgeX Therapeutics Reports Fourth Quarter and Annual 2022 Financial Results Business Wire - Fri Mar 31, 2023

AgeX Therapeutics, Inc. (“AgeX”; NYSE American: AGE), a biotechnology company developing therapeutics for human aging and regeneration, reported its financial and operating results for fourth quarter...

AGE : 11.10 (-11.90%)

Barchart Exclusives

Dividend Newcomers: Discover 3 Companies Starting To Share the Wealth Barchart - Fri Apr 19, 6:00PM CDT
Discover the potential of newly initiated dividends—start building your wealth with tomorrow's top dividend payers today! Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar

[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot